Table 2 Baseline characteristics of patients included
Baseline characteristics | AL (1996–2014) | ASAQ (2002–2014) | ASMQ (2002–2013) | DP (2002–2013) | Total (1996–2014) |
|---|---|---|---|---|---|
N | 16,373 | 4850 | 1220 | 9064 | 31,507 |
Gender | |||||
Femalea | 7394 (45.2%) | 2253 (46.5%) | 591 (48.4%) | 3464 (38.2%) | 13,702 (43.5%) |
Age (years)a | |||||
Mean age ± SD (years) | 8.3 ± 10.66 | 7.0 ± 9.21 | 11.9 ± 13.37 | 13.5 ± 14.09 | 9.8 ± 11.94 |
< 1 year | 924 (5.6%) | 312 (6.4%) | 65 (5.3%) | 386 (4.3%) | 1687 (5.4%) |
1 to < 5 years | 8629 (52.7%) | 2895 (59.7%) | 522 (42.8%) | 3736 (41.2%) | 15,782 (50.1%) |
5 to < 12 years | 3306 (20.2%) | 773 (15.9%) | 201 (16.5%) | 1264 (13.9%) | 5544 (17.6%) |
≥ 12 years | 3491 (21.3%) | 862 (17.8%) | 426 (34.9%) | 3665 (40.4%) | 8444 (26.8%) |
Missing | 23 (0.1%) | 8 (0.2%) | 6 (0.5%) | 13 (0.1%) | 50 (0.2%) |
Continenta | |||||
Africa | 14,087 (86.0%) | 4550 (93.8%) | 810 (66.4%) | 4862 (53.6%) | 24,309 (77.2%) |
Asia | 2127 (13.0%) | 300 (6.2%) | 410 (33.7%) | 3950 (43.6%) | 6787 (21.5%) |
South America | 159 (1.0%) | 0 (0.0%) | 0 (0.0%) | 252 (2.8%) | 411 (1.3%) |
Enrolment clinical parameters | |||||
Mean body weight ± SD (kg) | 20.9 ± 16.29 | 20.0 ± 16.02 | 23.7 ± 17.2 | 22.4 ± 17.55 | 21.2 ± 16.63 |
Mean haemoglobin ± SD (g/dL) | 10.2 ± 2.21 | 9.6 ± 1.98 | 10.4 ± 2.26 | 10.2 ± 2.31 | 10.1 ± 2.22 |
Median parasitaemia [IQR] (/µL) | 19,674 [5590–50,550] | 21,730 [7353–53,439] | 23,386 [5953–64,103] | 14,320 [4178–43,337] | 18,576 [5284–49,520] |
Elevated temperature (> 37.5°) | 64.3% [9705/15,101] | 67.9% [3221/4747] | 74.0% [743/1004] | 60.2% [4200/6972] | 64.2% [17,869/27,824] |